Are We Prepared To Manage Anticoagulated ICH Patients or Should We Direct Them Elsewhere?

June 28, 2022

How and where to treat ICH patients- politics, reversal agents, and science all in one podcast!

1 Comments

Tweet Share

AI in Imaging - We All Know It’s Coming. Are We Ready for the Machines in Stroke?

June 21, 2022

AI is coming but are we ready for it in stroke imaging?

0 Comments

Tweet Share

Telemedicine and Stroke: What Have We Done?

June 14, 2022

Is telemedicine the savior for stroke care or the start part of the downfall of acute medicine?

0 Comments

Tweet Share

Stroke Center Designations Are Big Business. Are They More Than That for Patient Care?

June 7, 2022

Stroke center designations are the currency of the realm; but does it matter to patients?

0 Comments

Tweet Share

Telemedicine and Acute Stroke Research: What Is the State of the Union?

May 24, 2022

Telemedicine is the future of stroke - is it the future of stroke research?

0 Comments

Tweet Share

RSS

Previous 1 2 3 4 5 6 7 8 9 10 Next Last

Sep 7

Why Is the Extended Window Controversial and What Happened With the FDA?

Haemin Go posted on 9/7/2021

Moderator: William A. Knight IV, MD, FACEP, FNCS
Other Participants: Stacie L. Demel, DO, PhD

The ECASS 3 trial was an RCT of IV-rtPA in the window of 3-4.5 hrs after onset of stroke symptoms. It was conducted in Europe. The European regulatory bodies have endorsed tPA for that window, but the FDA has not. Listen to two national experts in stroke discuss the trial and the meaning of the endorsement or lack thereof. This podcast is a must for acute stroke practitioners!

Podcast, ED First Patient Contact, Care Team, EM, Neuro, Nursing, Pharm, Stroke Team, Time From Stroke, 01_< 6 hrs, Topics, Controversies, Tx Approach, Types Of Content, Podcast, Testing, Triage & Disability Assessment, Care Team, EM, Neuro, Stroke Team, Fibrinolytic Therapy, Care Team, EM, Hosp Med, Neuro, Neurophys, Stroke Team, Diagnosis, IS, Topics, Controversies, EBM, IV Rx, Lytic Therapy, Standard Care, Treatments, Types of Content, Podcast, ICU & Critical Care, Care Team, Critical Care, Hosp Med, Neuro, Stroke Team, Topics, Bleeding, Controversies, EBM, Types of Content, Podcast, Content Types, Podcast

2 Comments

Tweet Share

2 Comments

2 comments on article "Why Is the Extended Window Controversial and What Happened With the FDA?"

Ken Milne

I watched the video on ECASS-III and you mentioned the controversy in this time window. However, there was no mention of Alper et al reanalysis in the BMJ_EBM that questioned the results? Can you comment? https://ebm.bmj.com/content/25/5/168

Ken Milne

Here was some of our feedback on Alper et al https://ebm.bmj.com/content/early/2020/08/10/bmjebm-2020-111517

Please login or register to post comments.

Assessing the ED Stroke Patient for Disability - What Are the Pitfalls and How to Avoid Them?

December 2, 2020

The NIH Stroke Scale is beneficial when used correctly but is has its limitations. Relying entirely on the NIHSS will miss significant disability in a...

0 Comments

The New Standards for Prehospital Stroke Patient Destinations; the Dawn of a New Era in EMS

March 11, 2021

The destination for prehospital patients with suspected stroke has been controversial for many years. Should they be taken to the closest ED, the closest...

0 Comments

What Was Missing From the NINDS Trial?

December 4, 2020

The NINDS trial was the seminal study of IV-tPA in the treatment of acute stroke. Yet controversy still exists around the trial methodology and the...

0 Comments

Confusion vs. Aphasia- So Important and So Challenging at Times!

March 15, 2022

Confusion isn't really a stroke symptom but aphasia clearly is. One is life threatening and the other can often be self limited and benign. Are you sure...

0 Comments

The Future of Mobile Stroke Units – The Frontier is Here…

November 12, 2020

In today’s technology-savvy world, we have come to expect getting goods and services delivered on demand and on our terms. We want things right away....

0 Comments

1 2 3 4 5 6 7 8 9 10 Next Last

STAY CONNECTED

Let’s expand your stroke education network. Follow us on Twitter to get the latest updates about stroke education and stay up-to-date on hot topics in stroke care.

ABOUT THE STROKE JOURNEY

The Stroke Journey is an initiative developed by The National Stroke Education Center (NSEC) that strives to be the premier source of educational information for the diagnosis and treatment of stroke in the United States. NSEC extends the world-class educational expertise of the University of Cincinnati Department of Emergency Medicine and its partners via a variety of traditional and digital resources. NSEC and The Stroke Journey are dedicated to providing outstanding stroke education with timely material that mirrors the real-time changes in the medical education and stroke care landscape.

OUR PARTNERS

The Stroke Journey is a collaboration between the NSEC, EMCREG-International, and MedEd On The Go. Together we are committed to providing high-quality stroke education for healthcare professionals.

Are We Prepared To Manage Anticoagulated ICH Patients or Should We Direct Them Elsewhere?

AI in Imaging - We All Know It’s Coming. Are We Ready for the Machines in Stroke?

Telemedicine and Stroke: What Have We Done?

Stroke Center Designations Are Big Business. Are They More Than That for Patient Care?

Telemedicine and Acute Stroke Research: What Is the State of the Union?

Archive

Categories

More Entries

Why Is the Extended Window Controversial and What Happened With the FDA?

2 comments on article "Why Is the Extended Window Controversial and What Happened With the FDA?"

Please login or register to post comments.